Table V.
Antibiotic resistance rates of carbapenem-resistant Enterobacterales (CRE) colonization and subsequent infection isolates (μg/mL)
| Antibiotics | CR-KP (%) |
CR-ECO (%) |
||
|---|---|---|---|---|
| Colonization (N = 23) | Infection (N = 23) | Colonization (N = 6) | Infection(N = 6) | |
| Ampicillin | –∗ | –∗ | 100 | 100 |
| Ampicillin–sulbactam | 100 | 100 | 83.3 | 83.3 |
| Piperacillin–Tazobactam | 91.3 | 95.7 | 66.7 | 66.7 |
| Cefazolin | 100 | 100 | 66.7 | 83.3 |
| Cefuroxime | 100 | 100 | 83.3 | 83.3 |
| Ceftazidime | 100 | 100 | 83.3 | 83.3 |
| Ceftriaxone | 100 | 100 | 100 | 100 |
| Cefepime | 60.9 | 65.2 | 83.3 | 83.3 |
| Ertapenem | 87 | 91.3 | 100 | 100 |
| Imipenem | 73.9 | 82.6 | 83.3 | 83.3 |
| Meropenem | 73.9 | 78.3 | 83.3 | 83.3 |
| Amikacin | 0 | 0 | 16.7 | 16.7 |
| Gentamicin | 0 | 0 | 50 | 66.7 |
| Ciprofloxacin | 0 | 0 | 66.7 | 66.7 |
| Levofloxacin | 0 | 0 | 66.7 | 83.3 |
| Trimethoprim/sulfamethoxazole | 4.3 | 8.7 | 66.7 | 66.7 |
CR-ECO, carbapenem-resistant Escherichia coli; CR-KP, carbapenem-resistant Klebsiella pneumoniae.
∗
Intrinsic resistance.